Feasibility of using the TOSCA telescreening procedures for diabetic retinopathy
Identifieur interne : 000967 ( Istex/Corpus ); précédent : 000966; suivant : 000968Feasibility of using the TOSCA telescreening procedures for diabetic retinopathy
Auteurs : S. Luzio ; S. Hatcher ; G. Zahlmann ; L. Mazik ; M. Morgan ; B. Liesenfeld ; T. Bek ; H. Schuell ; S. Schneider ; D. R. Owens ; E. KohnerSource :
- Diabetic Medicine [ 0742-3071 ] ; 2004-10.
English descriptors
Abstract
Aims The TOSCA project was set up to establish a tele‐ophthalmology service to screen for diabetic retinopathy (DR) in Europe. The aim of this study was to determine the feasibility of establishing telemedicine‐based digital screening for detecting DR and to evaluate the satisfaction of both patients and healthcare professionals with the screening procedures used within the TOSCA project.
Url:
DOI: 10.1111/j.1464-5491.2004.01305.x
Links to Exploration step
ISTEX:5F14993FB747187177FF7E4D9798779188F9A835Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Feasibility of using the TOSCA telescreening procedures for diabetic retinopathy</title><author><name sortKey="Luzio, S" sort="Luzio, S" uniqKey="Luzio S" first="S." last="Luzio">S. Luzio</name><affiliation><mods:affiliation>Diabetes Research Unit, Penarth, UK,</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: luzio@cardiff.ac.uk</mods:affiliation></affiliation></author><author><name sortKey="Hatcher, S" sort="Hatcher, S" uniqKey="Hatcher S" first="S." last="Hatcher">S. Hatcher</name><affiliation><mods:affiliation>Diabetes Research Unit, Penarth, UK,</mods:affiliation></affiliation></author><author><name sortKey="Zahlmann, G" sort="Zahlmann, G" uniqKey="Zahlmann G" first="G." last="Zahlmann">G. Zahlmann</name><affiliation><mods:affiliation>Siemens MED, Erlangen, Germany</mods:affiliation></affiliation></author><author><name sortKey="Mazik, L" sort="Mazik, L" uniqKey="Mazik L" first="L." last="Mazik">L. Mazik</name><affiliation><mods:affiliation>Charles University Hospital, Prague, Czech Republic</mods:affiliation></affiliation></author><author><name sortKey="Morgan, M" sort="Morgan, M" uniqKey="Morgan M" first="M." last="Morgan">M. Morgan</name><affiliation><mods:affiliation>Irish Diabetic Retinopathy Study Group, Dublin, Eire</mods:affiliation></affiliation></author><author><name sortKey="Liesenfeld, B" sort="Liesenfeld, B" uniqKey="Liesenfeld B" first="B." last="Liesenfeld">B. Liesenfeld</name><affiliation><mods:affiliation>BruderKrankenhaus, Trier, Germany</mods:affiliation></affiliation></author><author><name sortKey="Bek, T" sort="Bek, T" uniqKey="Bek T" first="T." last="Bek">T. Bek</name><affiliation><mods:affiliation>University Hospital, Aarhus, Denmark</mods:affiliation></affiliation></author><author><name sortKey="Schuell, H" sort="Schuell, H" uniqKey="Schuell H" first="H." last="Schuell">H. Schuell</name><affiliation><mods:affiliation>Siemens MED, Erlangen, Germany</mods:affiliation></affiliation></author><author><name sortKey="Schneider, S" sort="Schneider, S" uniqKey="Schneider S" first="S." last="Schneider">S. Schneider</name><affiliation><mods:affiliation>Siemens MED, Erlangen, Germany</mods:affiliation></affiliation></author><author><name sortKey="Owens, D R" sort="Owens, D R" uniqKey="Owens D" first="D. R." last="Owens">D. R. Owens</name><affiliation><mods:affiliation>Diabetes Research Unit, Penarth, UK,</mods:affiliation></affiliation></author><author><name sortKey="Kohner, E" sort="Kohner, E" uniqKey="Kohner E" first="E." last="Kohner">E. Kohner</name><affiliation><mods:affiliation>ICSTM, London, UK</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:5F14993FB747187177FF7E4D9798779188F9A835</idno><date when="2004" year="2004">2004</date><idno type="doi">10.1111/j.1464-5491.2004.01305.x</idno><idno type="url">https://api.istex.fr/document/5F14993FB747187177FF7E4D9798779188F9A835/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000967</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000967</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Feasibility of using the TOSCA telescreening procedures for diabetic retinopathy</title><author><name sortKey="Luzio, S" sort="Luzio, S" uniqKey="Luzio S" first="S." last="Luzio">S. Luzio</name><affiliation><mods:affiliation>Diabetes Research Unit, Penarth, UK,</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: luzio@cardiff.ac.uk</mods:affiliation></affiliation></author><author><name sortKey="Hatcher, S" sort="Hatcher, S" uniqKey="Hatcher S" first="S." last="Hatcher">S. Hatcher</name><affiliation><mods:affiliation>Diabetes Research Unit, Penarth, UK,</mods:affiliation></affiliation></author><author><name sortKey="Zahlmann, G" sort="Zahlmann, G" uniqKey="Zahlmann G" first="G." last="Zahlmann">G. Zahlmann</name><affiliation><mods:affiliation>Siemens MED, Erlangen, Germany</mods:affiliation></affiliation></author><author><name sortKey="Mazik, L" sort="Mazik, L" uniqKey="Mazik L" first="L." last="Mazik">L. Mazik</name><affiliation><mods:affiliation>Charles University Hospital, Prague, Czech Republic</mods:affiliation></affiliation></author><author><name sortKey="Morgan, M" sort="Morgan, M" uniqKey="Morgan M" first="M." last="Morgan">M. Morgan</name><affiliation><mods:affiliation>Irish Diabetic Retinopathy Study Group, Dublin, Eire</mods:affiliation></affiliation></author><author><name sortKey="Liesenfeld, B" sort="Liesenfeld, B" uniqKey="Liesenfeld B" first="B." last="Liesenfeld">B. Liesenfeld</name><affiliation><mods:affiliation>BruderKrankenhaus, Trier, Germany</mods:affiliation></affiliation></author><author><name sortKey="Bek, T" sort="Bek, T" uniqKey="Bek T" first="T." last="Bek">T. Bek</name><affiliation><mods:affiliation>University Hospital, Aarhus, Denmark</mods:affiliation></affiliation></author><author><name sortKey="Schuell, H" sort="Schuell, H" uniqKey="Schuell H" first="H." last="Schuell">H. Schuell</name><affiliation><mods:affiliation>Siemens MED, Erlangen, Germany</mods:affiliation></affiliation></author><author><name sortKey="Schneider, S" sort="Schneider, S" uniqKey="Schneider S" first="S." last="Schneider">S. Schneider</name><affiliation><mods:affiliation>Siemens MED, Erlangen, Germany</mods:affiliation></affiliation></author><author><name sortKey="Owens, D R" sort="Owens, D R" uniqKey="Owens D" first="D. R." last="Owens">D. R. Owens</name><affiliation><mods:affiliation>Diabetes Research Unit, Penarth, UK,</mods:affiliation></affiliation></author><author><name sortKey="Kohner, E" sort="Kohner, E" uniqKey="Kohner E" first="E." last="Kohner">E. Kohner</name><affiliation><mods:affiliation>ICSTM, London, UK</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Diabetic Medicine</title><idno type="ISSN">0742-3071</idno><idno type="eISSN">1464-5491</idno><imprint><publisher>Blackwell Science Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2004-10">2004-10</date><biblScope unit="volume">21</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="1121">1121</biblScope><biblScope unit="page" to="1128">1128</biblScope></imprint><idno type="ISSN">0742-3071</idno></series><idno type="istex">5F14993FB747187177FF7E4D9798779188F9A835</idno><idno type="DOI">10.1111/j.1464-5491.2004.01305.x</idno><idno type="ArticleID">DME1305</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0742-3071</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>diabetic retinopathy</term><term>quality assurance</term><term>screening</term><term>telemedicine</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Aims The TOSCA project was set up to establish a tele‐ophthalmology service to screen for diabetic retinopathy (DR) in Europe. The aim of this study was to determine the feasibility of establishing telemedicine‐based digital screening for detecting DR and to evaluate the satisfaction of both patients and healthcare professionals with the screening procedures used within the TOSCA project.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>S. Luzio</name><affiliations><json:string>Diabetes Research Unit, Penarth, UK,</json:string><json:string>E-mail: luzio@cardiff.ac.uk</json:string></affiliations></json:item><json:item><name>S. Hatcher</name><affiliations><json:string>Diabetes Research Unit, Penarth, UK,</json:string></affiliations></json:item><json:item><name>G. Zahlmann</name><affiliations><json:string>Siemens MED, Erlangen, Germany</json:string></affiliations></json:item><json:item><name>L. Mazik</name><affiliations><json:string>Charles University Hospital, Prague, Czech Republic</json:string></affiliations></json:item><json:item><name>M. Morgan</name><affiliations><json:string>Irish Diabetic Retinopathy Study Group, Dublin, Eire</json:string></affiliations></json:item><json:item><name>B. Liesenfeld</name><affiliations><json:string>BruderKrankenhaus, Trier, Germany</json:string></affiliations></json:item><json:item><name>T. Bek</name><affiliations><json:string>University Hospital, Aarhus, Denmark</json:string></affiliations></json:item><json:item><name>H. Schuell</name><affiliations><json:string>Siemens MED, Erlangen, Germany</json:string></affiliations></json:item><json:item><name>S. Schneider</name><affiliations><json:string>Siemens MED, Erlangen, Germany</json:string></affiliations></json:item><json:item><name>D. R. Owens</name><affiliations><json:string>Diabetes Research Unit, Penarth, UK,</json:string></affiliations></json:item><json:item><name>E. Kohner</name><affiliations><json:string>ICSTM, London, UK</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>diabetic retinopathy</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>quality assurance</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>screening</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>telemedicine</value></json:item></subject><articleId><json:string>DME1305</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><qualityIndicators><score>3.926</score><pdfVersion>1.3</pdfVersion><pdfPageSize>595 x 782 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>392</abstractCharCount><pdfWordCount>3230</pdfWordCount><pdfCharCount>21501</pdfCharCount><pdfPageCount>8</pdfPageCount><abstractWordCount>58</abstractWordCount></qualityIndicators><title>Feasibility of using the TOSCA telescreening procedures for diabetic retinopathy</title><refBibs><json:item><author><json:item><name>AF Amos</name></json:item><json:item><name>D McCarty</name></json:item><json:item><name>P Zimmet</name></json:item></author><host><volume>14</volume><pages><last>85</last><first>7</first></pages><issue>Suppl. 5</issue><author></author><title>Diabetic Med</title></host><title>The rising global burden of diabetes and its complications; estimates and projections to the year 2010</title></json:item><json:item><author><json:item><name>H King</name></json:item><json:item><name>RE Aubert</name></json:item><json:item><name>WH Herman</name></json:item></author><host><volume>21</volume><pages><last>1431</last><first>1414</first></pages><author></author><title>Diabetes Care</title></host><title>Global burden of diabetes 1995–2025; prevalence, numerical estimates and projections</title></json:item><json:item><author><json:item><name>DR Owens</name></json:item><json:item><name>J Dolben</name></json:item><json:item><name>JP Vora</name></json:item><json:item><name>SD Luzio</name></json:item><json:item><name>S Williams</name></json:item><json:item><name>S Young</name></json:item></author><host><pages><last>119</last><first>111</first></pages><author></author><title>Excerpta Medica</title></host><title>Retinopathy and nephropathy in relationship to metabolic status in newly diagnosed NIDDM</title></json:item><json:item><author><json:item><name> </name></json:item></author><host><volume>352</volume><pages><last>853</last><first>837</first></pages><author></author><title>Lancet</title></host><title>Intensive blood‐glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33)</title></json:item><json:item><author><json:item><name>PD Home</name></json:item></author><host><volume>308</volume><pages><last>612</last><first>611</first></pages><author></author><title>Br Med J</title></host><title>Diagnosing the undiagnosed with diabetes</title></json:item><json:item><host><author></author><title>Marks L. Counting the Cost: The Real Impact of Non‐insulin Dependent Diabetes.London: Kings Fund Policy Unit, 1996.</title></host></json:item><json:item><author><json:item><name>R Williams</name></json:item><json:item><name>L Van Gaal</name></json:item><json:item><name>C Lucioni</name></json:item></author><host><volume>45</volume><pages><last>17</last><first>13</first></pages><author></author><title>Diabetologia</title></host><title>Assessing the impact of complications on the costs of Type 2 diabetes</title></json:item><json:item><author><json:item><name>JA O'Brien</name></json:item><json:item><name>LA Shomphe</name></json:item><json:item><name>PL Kavanagh</name></json:item><json:item><name>G Raggio</name></json:item><json:item><name>JJ Caro</name></json:item></author><host><volume>21</volume><pages><last>1128</last><first>1122</first></pages><author></author><title>Diabetes Care</title></host><title>Direct medical costs of complications resulting from Type 2 diabetes in the US</title></json:item><json:item><author><json:item><name>EM Kohner</name></json:item><json:item><name>SJ Aldington</name></json:item><json:item><name>IM Stratton</name></json:item><json:item><name>SE Manley</name></json:item><json:item><name>RR Holman</name></json:item><json:item><name>DR Matthews</name></json:item></author><host><volume>16</volume><pages><last>303</last><first>297</first></pages><author></author><title>Arch Ophthalmol</title></host><title>United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non‐insulin dependent diabetes mellitus and associated risk factors</title></json:item><json:item><author><json:item><name>K Kristinsson</name></json:item></author><host><volume>75</volume><pages><first>223</first></pages><author></author><title>Acta Ophthalmologica Scand</title></host><title>Diabetic retinopathy—screening and prevention of blindness</title></json:item><json:item><author><json:item><name>JC Javitt</name></json:item><json:item><name>FL Ferris</name></json:item><json:item><name>L Aeillo</name></json:item><json:item><name>JK Canner</name></json:item><json:item><name>Y Chiang</name></json:item><json:item><name>S Greenfield</name></json:item></author><host><volume>17</volume><pages><last>917</last><first>909</first></pages><author></author><title>Diabetes Care</title></host><title>Preventative eye care in people with diabetes is cost saving to the Federal Government. Implications for health reform</title></json:item><json:item><author><json:item><name>JC Javitt</name></json:item><json:item><name>L Aiello</name></json:item></author><host><volume>124</volume><pages><last>169</last><first>164</first></pages><author></author><title>Ann Intern Med</title></host><title>Cost effectiveness of detecting and treating diabetic retinopathy</title></json:item><json:item><author><json:item><name>M Porta</name></json:item><json:item><name>A Rizzitiello</name></json:item><json:item><name>M Tomalino</name></json:item><json:item><name>M Trento</name></json:item><json:item><name>P Passera</name></json:item><json:item><name>A Mininne</name></json:item></author><host><volume>25</volume><pages><last>53</last><first>44</first></pages><author></author><title>Diabetes Metab</title></host><title>A comparison of the cost effectiveness of three approaches to screen for sight threatening diabetic retinopathy</title></json:item><json:item><author><json:item><name>M James</name></json:item><json:item><name>DA Turner</name></json:item><json:item><name>DM Broadbent</name></json:item><json:item><name>J Vora</name></json:item><json:item><name>SP Harding</name></json:item></author><host><volume>320</volume><pages><last>1631</last><first>1627</first></pages><author></author><title>Br Med J</title></host><title>Cost effectiveness analysis of screening for sight threatening diabetic retinopathy</title></json:item><json:item><author><json:item><name>P Bagga</name></json:item><json:item><name>D Verma</name></json:item><json:item><name>C Walton</name></json:item><json:item><name>EA Masson</name></json:item><json:item><name>DA Hepburn</name></json:item></author><host><volume>15</volume><pages><last>782</last><first>780</first></pages><author></author><title>Diabet Med</title></host><title>Survey of diabetic retinopathy screening services in England and Wales</title></json:item><json:item><author><json:item><name>S Young</name></json:item><json:item><name>LD George</name></json:item><json:item><name>J Lusty</name></json:item><json:item><name>DR Owens</name></json:item></author><host><volume>20</volume><pages><last>14</last><first>11</first></pages><author></author><title>J Audiovis Media Med</title></host><title>A new screening tool for diabetic retinopathy: the Canon CR5 45NM retinal camera with Frost Medical Software RIS‐Lite digital imaging system</title></json:item><json:item><author><json:item><name>DR Owens</name></json:item><json:item><name>RL Gibbins</name></json:item><json:item><name>E Kohner</name></json:item><json:item><name>GM Grimshaw</name></json:item><json:item><name>R Greenwood</name></json:item><json:item><name>S Harding</name></json:item></author><host><volume>17</volume><pages><last>494</last><first>493</first></pages><author></author><title>Diabet Med</title></host><title>Diabetic retinopathy screening</title></json:item><json:item><author><json:item><name>A Hutchinson</name></json:item><json:item><name>A McIntosh</name></json:item><json:item><name>J Peters</name></json:item><json:item><name>C O'Keeffe</name></json:item><json:item><name>K Khunti</name></json:item><json:item><name>R Baker</name></json:item></author><host><volume>17</volume><pages><last>506</last><first>495</first></pages><author></author><title>Diabet Med</title></host><title>Effectiveness of screening and monitoring tests for diabetic retinopathy—a systematic review</title></json:item><json:item><author><json:item><name>V Schmidt</name></json:item><json:item><name>W Striebel</name></json:item><json:item><name>G Michelson</name></json:item><json:item><name>D Shanit</name></json:item></author><host><volume>67</volume><pages><last>16</last><first>13</first></pages><issue>2</issue><author></author><title>Electromedica</title></host><title>MedStage—an internet‐based platform for telemedicine applications</title></json:item><json:item><author><json:item><name>RL Gibbins</name></json:item><json:item><name>DR Owens</name></json:item><json:item><name>J Allen</name></json:item><json:item><name>L Eastman</name></json:item></author><host><volume>41</volume><pages><last>64</last><first>59</first></pages><author></author><title>Diabetologia</title></host><title>Practical application of the European Field Guide in screening for diabetic retinopathy using ophthalmoscopy and 35mm retinal slides</title></json:item><json:item><author><json:item><name>L Garvican</name></json:item><json:item><name>J Clowes</name></json:item><json:item><name>T Gillow</name></json:item></author><host><volume>17</volume><pages><last>634</last><first>627</first></pages><author></author><title>Diabet Med</title></host><title>Preservation of sight in diabetes: developing a national risk reduction programme</title></json:item><json:item><host><author></author><title>Grimshaw GM, Baker R, Wilson AD, Thompson JR, Atkinson M. Report of the Inter College Audit of Diabetic Retinopathy Screening.Leicester: Clinical Governance Research and Development Unit, University of Leicester, 1999.</title></host></json:item><json:item><author><json:item><name>RJ Pandit</name></json:item><json:item><name>R Taylor</name></json:item></author><host><volume>19</volume><pages><last>291</last><first>285</first></pages><author></author><title>Diabet Med</title></host><title>Quality assurance in screening for sight threatening diabetic retinopathy</title></json:item></refBibs><genre><json:string>article</json:string></genre><host><volume>21</volume><publisherId><json:string>DME</json:string></publisherId><pages><total>8</total><last>1128</last><first>1121</first></pages><issn><json:string>0742-3071</json:string></issn><issue>10</issue><genre><json:string>journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1464-5491</json:string></eissn><title>Diabetic Medicine</title><doi><json:string>10.1111/(ISSN)1464-5491</json:string></doi></host><categories><wos><json:string>science</json:string><json:string>endocrinology & metabolism</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>endocrinology & metabolism</json:string></scienceMetrix></categories><publicationDate>2004</publicationDate><copyrightDate>2004</copyrightDate><doi><json:string>10.1111/j.1464-5491.2004.01305.x</json:string></doi><id>5F14993FB747187177FF7E4D9798779188F9A835</id><score>0.2560421</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/5F14993FB747187177FF7E4D9798779188F9A835/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/5F14993FB747187177FF7E4D9798779188F9A835/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/5F14993FB747187177FF7E4D9798779188F9A835/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Feasibility of using the TOSCA telescreening procedures for diabetic retinopathy</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Science Ltd</publisher><pubPlace>Oxford, UK</pubPlace><availability><p>WILEY</p></availability><date>2004</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Feasibility of using the TOSCA telescreening procedures for diabetic retinopathy</title><author xml:id="author-1"><persName><forename type="first">S.</forename><surname>Luzio</surname></persName><email>luzio@cardiff.ac.uk</email><affiliation>Diabetes Research Unit, Penarth, UK,</affiliation></author><author xml:id="author-2"><persName><forename type="first">S.</forename><surname>Hatcher</surname></persName><affiliation>Diabetes Research Unit, Penarth, UK,</affiliation></author><author xml:id="author-3"><persName><forename type="first">G.</forename><surname>Zahlmann</surname></persName><affiliation>Siemens MED, Erlangen, Germany</affiliation></author><author xml:id="author-4"><persName><forename type="first">L.</forename><surname>Mazik</surname></persName><affiliation>Charles University Hospital, Prague, Czech Republic</affiliation></author><author xml:id="author-5"><persName><forename type="first">M.</forename><surname>Morgan</surname></persName><affiliation>Irish Diabetic Retinopathy Study Group, Dublin, Eire</affiliation></author><author xml:id="author-6"><persName><forename type="first">B.</forename><surname>Liesenfeld</surname></persName><affiliation>BruderKrankenhaus, Trier, Germany</affiliation></author><author xml:id="author-7"><persName><forename type="first">T.</forename><surname>Bek</surname></persName><affiliation>University Hospital, Aarhus, Denmark</affiliation></author><author xml:id="author-8"><persName><forename type="first">H.</forename><surname>Schuell</surname></persName><affiliation>Siemens MED, Erlangen, Germany</affiliation></author><author xml:id="author-9"><persName><forename type="first">S.</forename><surname>Schneider</surname></persName><affiliation>Siemens MED, Erlangen, Germany</affiliation></author><author xml:id="author-10"><persName><forename type="first">D. R.</forename><surname>Owens</surname></persName><affiliation>Diabetes Research Unit, Penarth, UK,</affiliation></author><author xml:id="author-11"><persName><forename type="first">E.</forename><surname>Kohner</surname></persName><affiliation>ICSTM, London, UK</affiliation></author></analytic><monogr><title level="j">Diabetic Medicine</title><idno type="pISSN">0742-3071</idno><idno type="eISSN">1464-5491</idno><idno type="DOI">10.1111/(ISSN)1464-5491</idno><imprint><publisher>Blackwell Science Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2004-10"></date><biblScope unit="volume">21</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="1121">1121</biblScope><biblScope unit="page" to="1128">1128</biblScope></imprint></monogr><idno type="istex">5F14993FB747187177FF7E4D9798779188F9A835</idno><idno type="DOI">10.1111/j.1464-5491.2004.01305.x</idno><idno type="ArticleID">DME1305</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2004</date></creation><langUsage><language ident="en">en</language></langUsage><abstract><p>Aims The TOSCA project was set up to establish a tele‐ophthalmology service to screen for diabetic retinopathy (DR) in Europe. The aim of this study was to determine the feasibility of establishing telemedicine‐based digital screening for detecting DR and to evaluate the satisfaction of both patients and healthcare professionals with the screening procedures used within the TOSCA project.</p></abstract><abstract><p>Methods The study was a non‐randomized, multicentre study carried out in four different countries over a period of 3 months.</p></abstract><abstract><p>Patients (n = 390) with diabetes aged > 12 years were included. Two digital retinal images per eye (macular and nasal) were taken and exported to a central server. Patients were asked to complete a questionnaire to assess satisfaction. Accredited graders carried out grading remotely and the results were reported back to the referring centre. Previously graded patient data chosen randomly to represent examples of both DR and no DR were also sent anonymously to the grading centre at a frequency of approximately every 10 patients.</p></abstract><abstract><p>Results Most (99%) of the images were assessable enabling a retinopathy grade to be assigned to the patient. Patients found the retinal photography procedures acceptable; only 6% in one centre would not recommend the procedure. Healthcare professionals (photographers and graders) were also satisfied with the overall procedures. The average time taken to grade each patient was approximately 5 min.</p></abstract><abstract><p>Conclusions This study demonstrated that it is feasible to electronically transmit and grade retinal images remotely using the TOSCA process. Built‐in quality assurance procedures proved acceptable.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>keywords</head><item><term>diabetic retinopathy</term></item><item><term>quality assurance</term></item><item><term>screening</term></item><item><term>telemedicine</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2004-10">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/5F14993FB747187177FF7E4D9798779188F9A835/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Science Ltd</publisherName><publisherLoc>Oxford, UK</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1464-5491</doi><issn type="print">0742-3071</issn><issn type="electronic">1464-5491</issn><idGroup><id type="product" value="DME"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="DIABETIC MEDICINE">Diabetic Medicine</title></titleGroup></publicationMeta><publicationMeta level="part" position="10010"><doi origin="wiley">10.1111/dme.2004.21.issue-10</doi><numberingGroup><numbering type="journalVolume" number="21">21</numbering><numbering type="journalIssue" number="10">10</numbering></numberingGroup><coverDate startDate="2004-10">October 2004</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="11" status="forIssue"><doi origin="wiley">10.1111/j.1464-5491.2004.01305.x</doi><idGroup><id type="unit" value="DME1305"></id></idGroup><countGroup><count type="pageTotal" number="8"></count></countGroup><titleGroup><title type="tocHeading1">Original Articles</title></titleGroup><eventGroup><event type="firstOnline" date="2004-06-25"></event><event type="publishedOnlineFinalForm" date="2004-09-22"></event><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.2 mode:FullText source:FullText result:FullText" date="2010-02-27"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-01-17"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-16"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="1121">1121</numbering><numbering type="pageLast" number="1128">1128</numbering></numberingGroup><correspondenceTo>Stephen Luzio, Diabetes Research Unit, Llandough Hospital, Penlan Road, Penarth, Cardiff, UK. E‐mail: <email>luzio@cardiff.ac.uk</email></correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:DME.DME1305.pdf"></link></linkGroup></publicationMeta><contentMeta><unparsedEditorialHistory>Accepted 11 December 2003</unparsedEditorialHistory><countGroup><count type="figureTotal" number="3"></count><count type="tableTotal" number="4"></count><count type="formulaTotal" number="0"></count><count type="referenceTotal" number="23"></count><count type="wordTotal" number="3879"></count></countGroup><titleGroup><title type="main">Feasibility of using the TOSCA telescreening procedures for diabetic retinopathy</title><title type="shortAuthors">TOSCA telescreening procedures for diabetic retinopathy <i>S. Luzio et al.</i></title><title type="short">Original article</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1" corresponding="yes"><personName><givenNames>S.</givenNames><familyName>Luzio</familyName></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#a1"><personName><givenNames>S.</givenNames><familyName>Hatcher</familyName></personName></creator><creator creatorRole="author" xml:id="cr3" affiliationRef="#a2"><personName><givenNames>G.</givenNames><familyName>Zahlmann</familyName></personName></creator><creator creatorRole="author" xml:id="cr4" affiliationRef="#a3"><personName><givenNames>L.</givenNames><familyName>Mazik</familyName></personName></creator><creator creatorRole="author" xml:id="cr5" affiliationRef="#a4"><personName><givenNames>M.</givenNames><familyName>Morgan</familyName></personName></creator><creator creatorRole="author" xml:id="cr6" affiliationRef="#a5"><personName><givenNames>B.</givenNames><familyName>Liesenfeld</familyName></personName></creator><creator creatorRole="author" xml:id="cr7" affiliationRef="#a6"><personName><givenNames>T.</givenNames><familyName>Bek</familyName></personName></creator><creator creatorRole="author" xml:id="cr8" affiliationRef="#a2"><personName><givenNames>H.</givenNames><familyName>Schuell</familyName></personName></creator><creator creatorRole="author" xml:id="cr9" affiliationRef="#a2"><personName><givenNames>S.</givenNames><familyName>Schneider</familyName></personName></creator><creator creatorRole="author" xml:id="cr10" affiliationRef="#a1"><personName><givenNames>D. R.</givenNames><familyName>Owens</familyName></personName></creator><creator creatorRole="author" xml:id="cr11" affiliationRef="#a7"><personName><givenNames>E.</givenNames><familyName>Kohner</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="a1"><unparsedAffiliation>Diabetes Research Unit, Penarth, UK,</unparsedAffiliation></affiliation><affiliation xml:id="a2" countryCode="DE"><unparsedAffiliation>Siemens MED, Erlangen, Germany</unparsedAffiliation></affiliation><affiliation xml:id="a3" countryCode="CZ"><unparsedAffiliation>Charles University Hospital, Prague, Czech Republic</unparsedAffiliation></affiliation><affiliation xml:id="a4"><unparsedAffiliation>Irish Diabetic Retinopathy Study Group, Dublin, Eire</unparsedAffiliation></affiliation><affiliation xml:id="a5" countryCode="DE"><unparsedAffiliation>BruderKrankenhaus, Trier, Germany</unparsedAffiliation></affiliation><affiliation xml:id="a6" countryCode="DK"><unparsedAffiliation>University Hospital, Aarhus, Denmark</unparsedAffiliation></affiliation><affiliation xml:id="a7" countryCode="GB"><unparsedAffiliation>ICSTM, London, UK</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en"><keyword xml:id="k1">diabetic retinopathy</keyword><keyword xml:id="k2">quality assurance</keyword><keyword xml:id="k3">screening</keyword><keyword xml:id="k4">telemedicine</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p><b>Aims </b> The TOSCA project was set up to establish a tele‐ophthalmology service to screen for diabetic retinopathy (DR) in Europe. The aim of this study was to determine the feasibility of establishing telemedicine‐based digital screening for detecting DR and to evaluate the satisfaction of both patients and healthcare professionals with the screening procedures used within the TOSCA project.</p><p><b>Methods </b> The study was a non‐randomized, multicentre study carried out in four different countries over a period of 3 months.</p><p><b>Patients </b> (<i>n</i> = 390) with diabetes aged > 12 years were included. Two digital retinal images per eye (macular and nasal) were taken and exported to a central server. Patients were asked to complete a questionnaire to assess satisfaction. Accredited graders carried out grading remotely and the results were reported back to the referring centre. Previously graded patient data chosen randomly to represent examples of both DR and no DR were also sent anonymously to the grading centre at a frequency of approximately every 10 patients.</p><p><b>Results </b> Most (99%) of the images were assessable enabling a retinopathy grade to be assigned to the patient. Patients found the retinal photography procedures acceptable; only 6% in one centre would not recommend the procedure. Healthcare professionals (photographers and graders) were also satisfied with the overall procedures. The average time taken to grade each patient was approximately 5 min.</p><p><b>Conclusions </b> This study demonstrated that it is feasible to electronically transmit and grade retinal images remotely using the TOSCA process. Built‐in quality assurance procedures proved acceptable.</p><!-- Diabet. Med. (2004)
</abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Feasibility of using the TOSCA telescreening procedures for diabetic retinopathy</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Original article</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Feasibility of using the TOSCA telescreening procedures for diabetic retinopathy</title></titleInfo><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Luzio</namePart><affiliation>Diabetes Research Unit, Penarth, UK,</affiliation><affiliation>E-mail: luzio@cardiff.ac.uk</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Hatcher</namePart><affiliation>Diabetes Research Unit, Penarth, UK,</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Zahlmann</namePart><affiliation>Siemens MED, Erlangen, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.</namePart><namePart type="family">Mazik</namePart><affiliation>Charles University Hospital, Prague, Czech Republic</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Morgan</namePart><affiliation>Irish Diabetic Retinopathy Study Group, Dublin, Eire</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Liesenfeld</namePart><affiliation>BruderKrankenhaus, Trier, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Bek</namePart><affiliation>University Hospital, Aarhus, Denmark</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H.</namePart><namePart type="family">Schuell</namePart><affiliation>Siemens MED, Erlangen, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Schneider</namePart><affiliation>Siemens MED, Erlangen, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D. R.</namePart><namePart type="family">Owens</namePart><affiliation>Diabetes Research Unit, Penarth, UK,</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Kohner</namePart><affiliation>ICSTM, London, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>Blackwell Science Ltd</publisher><place><placeTerm type="text">Oxford, UK</placeTerm></place><dateIssued encoding="w3cdtf">2004-10</dateIssued><edition>Accepted 11 December 2003</edition><copyrightDate encoding="w3cdtf">2004</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">3</extent><extent unit="tables">4</extent><extent unit="references">23</extent><extent unit="words">3879</extent></physicalDescription><abstract>Aims The TOSCA project was set up to establish a tele‐ophthalmology service to screen for diabetic retinopathy (DR) in Europe. The aim of this study was to determine the feasibility of establishing telemedicine‐based digital screening for detecting DR and to evaluate the satisfaction of both patients and healthcare professionals with the screening procedures used within the TOSCA project.</abstract><abstract>Methods The study was a non‐randomized, multicentre study carried out in four different countries over a period of 3 months.</abstract><abstract>Patients (n = 390) with diabetes aged > 12 years were included. Two digital retinal images per eye (macular and nasal) were taken and exported to a central server. Patients were asked to complete a questionnaire to assess satisfaction. Accredited graders carried out grading remotely and the results were reported back to the referring centre. Previously graded patient data chosen randomly to represent examples of both DR and no DR were also sent anonymously to the grading centre at a frequency of approximately every 10 patients.</abstract><abstract>Results Most (99%) of the images were assessable enabling a retinopathy grade to be assigned to the patient. Patients found the retinal photography procedures acceptable; only 6% in one centre would not recommend the procedure. Healthcare professionals (photographers and graders) were also satisfied with the overall procedures. The average time taken to grade each patient was approximately 5 min.</abstract><abstract>Conclusions This study demonstrated that it is feasible to electronically transmit and grade retinal images remotely using the TOSCA process. Built‐in quality assurance procedures proved acceptable.</abstract><subject lang="en"><genre>keywords</genre><topic>diabetic retinopathy</topic><topic>quality assurance</topic><topic>screening</topic><topic>telemedicine</topic></subject><relatedItem type="host"><titleInfo><title>Diabetic Medicine</title></titleInfo><genre type="journal">journal</genre><identifier type="ISSN">0742-3071</identifier><identifier type="eISSN">1464-5491</identifier><identifier type="DOI">10.1111/(ISSN)1464-5491</identifier><identifier type="PublisherID">DME</identifier><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><detail type="issue"><caption>no.</caption><number>10</number></detail><extent unit="pages"><start>1121</start><end>1128</end><total>8</total></extent></part></relatedItem><identifier type="istex">5F14993FB747187177FF7E4D9798779188F9A835</identifier><identifier type="DOI">10.1111/j.1464-5491.2004.01305.x</identifier><identifier type="ArticleID">DME1305</identifier><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Blackwell Science Ltd</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Rhénanie/explor/UnivTrevesV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000967 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000967 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Rhénanie
|area= UnivTrevesV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:5F14993FB747187177FF7E4D9798779188F9A835
|texte= Feasibility of using the TOSCA telescreening procedures for diabetic retinopathy
}}
| This area was generated with Dilib version V0.6.31. |  |